首页> 外文期刊>European journal of gynaecological oncology >Plasma fibrinogen, CRP, and hs-CRP levels in patients with benign and borderline ovarian tumours
【24h】

Plasma fibrinogen, CRP, and hs-CRP levels in patients with benign and borderline ovarian tumours

机译:良性和边缘卵巢肿瘤患者的血浆纤维蛋白原,CRP和HS-CRP水平

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Ovarian tumours can be classified as benign, borderline or malignant lesions. The purpose of this study was to assess, inter alia, fibrinogen concentration, and the (C-reactive proteins) and high-sensitivity CRPs (hs-CRPs) levels in the blood serum of patients with ovarian lesions. Study Design: The study involved patients treated laparoscopically and laparotomy in the Gynaecology and Obstetrics Clinical Hospital of the Poznan due to adnexal changes in the form of endometrial cysts and mature teratomas, mucinous cysts, borderline tumors of the ovary, simplex (serosa) cysts or haemorrhagic cysts. Results: The groups differed considerably in fibrinogen (p = 0.022) and d-dimer levels (p = 0.002). Conclusion: Statistically significant differences were found in the fibrinogen and d-dimer profiles among patients with benign and borderline ovarian tumours. However, this requires further investigations in larger patient groups.
机译:目的:卵巢肿瘤可归类为良性,边界或恶性病变。 本研究的目的是尤其是纤维蛋白原浓度和卵巢病变患者血清中的(C反应蛋白)和高灵敏度CRP(HS-CRPS)水平。 研究设计:由于子宫内膜囊肿和成熟畸胎瘤,粘液囊肿,卵巢的边缘肿瘤,卵巢,单纯纤维(Serosa)或 出血性囊肿。 结果:纤维蛋白原(P = 0.022)和D-二聚体水平相比不同(P = 0.002)。 结论:良性和边缘卵巢肿瘤患者纤维蛋白原和D-二聚体谱中发现统计学显着差异。 然而,这需要进一步调查较大的患者群体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号